Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from KYORIN Pharmaceutical Co.,Ltd. ( (JP:4569) ) is now available.
KYORIN Pharmaceutical Co., Ltd. announced executive personnel changes effective June 20, 2025, involving key positions within its Board of Directors and Corporate Officers. These changes are part of the company’s strategic realignment to enhance operational efficiency and strengthen leadership within its group facilities.
More about KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is known for its commitment to quality assurance and reliability in its market offerings.
Average Trading Volume: 162,224
Technical Sentiment Signal: Sell
Current Market Cap: Yen85.27B
For detailed information about 4569 stock, go to TipRanks’ Stock Analysis page.